Tähelepanu! Artikkel on enam kui 5 aastat vana ning kuulub väljaande digitaalsesse arhiivi. Väljaanne ei uuenda ega kaasajasta arhiveeritud sisu, mistõttu võib olla vajalik kaasaegsete allikatega tutvumine.
Stem Cell Innovations and ALS Association announce collaboration
Houston TX- USA and Calabasas Hills- CA- USA - December 11-
2006 - Stem Cell Innovations- Inc. (SCLL.OB) and The ALS
Association- a non-profit health organization dedicated to finding
a cure for amyotrophic lateral sclerosis (ALS)- announced today a
two-year discovery alliance. Stem Cell Innovations (SCI) will
develop human motor neuron models based on its proprietary
PluriCell(TM) technology that can be used for high-throughput
screening. Subsequently- the cell models will be used by alliance
partner Galapagos to discover novel drug targets for ALS. Under the
terms of the agreement- SCI will receive 400-000 Euros ($512-000)
from The ALS Association- upon completion of certain milestones. In
addition- SCI has the option to further develop certain
cell-therapy applications based on results identified in the
"The human motor neuron cultures derived from our PluriCellswill form the basis of this exciting alliance-" said Stem CellInnovations CEO Dr. James Kelly. "We are very pleased to becollaborating with The ALS Association and Galapagos on thisdiscovery project."
"The unique ability provided by SCI to screen human motorneurons at large scale will open new approaches to developingmedicines that may stop ALS-" said Dr. Lucie Bruijn- ScienceDirector and Vice President at The ALS Association. "We see thisalliance with SCI as an important initiative within the ALSAssociation's mission to find a cure for and improve living withALS."